The US Bankruptcy Court gave an order approving the sale of substantially all the assets of Impel Pharmaceuticals Inc. on February 2, 2024. The debtor has been authorized to sell substantially all its assets to JN Bidco LLC, for a purchase price of $17.5 million in cash. The debtor did not receive any other competing bids for the purchase of its assets and therefore JN Bidco LLC emerged as the winning bidder.